Skip to content

Clinical trials

Phase 1/2 Hematologic Diseases trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 1/2 Status: Unknown status Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20111
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hellenic Society of Hematology1
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy1
Senesco Technologies, Inc.1
University Hospital Freiburg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases4
Blood Protein Disorders2
Multiple Myeloma2
Neoplasms, Plasma Cell2
Corneal Diseases1
Leukemia, Plasma Cell1
Lymphoma, B-Cell1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Mantle-Cell1
Neoplasms1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.